Annual report pursuant to Section 13 and 15(d)

Segmented Information

v3.5.0.2
Segmented Information
12 Months Ended
Aug. 31, 2016
Segmented Information [Text Block]
16.

Segment Information

   
 

The Company’s operations involve the development and usage, including licensing, of its proprietary nutrient infusion Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health products as well as licensing, as a whole, to make operational decisions and to assess the performance of the Company. Accordingly, the Company operates in a single segment.

   
 

During the year ended August 31, 2015, the Company’s operating segments were the oil and gas exploration and the alternative health products, which were managed separately based on fundamental differences in the nature of such operations.

   
 

Summarized financial information concerning Lexaria’s reportable segment as at and during the year ended August 31, 2015 was as follows:


            Alternative              
      Oil and Gas     Health Products     Corporate     Total  
          $     $     $  
  Revenue   48,918     14,702     -     63,620  
  Operation expenses   -     349,093     1,618,996     1,968,089  
  Total assets   -     214,632     497,090     711,722